source
- Biopharma layoffs must double in second half of 2026 to match 2025 cutsThe first half of 2026 saw biopharma companies cut slightly fewer jobs than the same period a year earlier, with layoffs affecting about 2% fewer employees overall. To reach the total workforce re…
- FDA says it has not paused CRL releases amid transparency pushAn unnamed pharmaceutical company filed a citizen petition in April asking the FDA to change how it publicly releases Complete Response Letters, arguing the new policy conflicts with long‑standing…